Cleavage of the antithrombin III binding site in heparin by heparinases and its implication in the generation of low molecular weight heparin
Heparin has been used as a clinical anticoagulant for more than 50 years, making it one of the most effective pharmacological agents known. Much of heparin's activity can be traced to its ability to bind antithrombin III (AT-III). Low molecular weight heparin (LMWH), derived from heparin by its cont...
Na minha lista:
| Publicado no: | Proc Natl Acad Sci U S A |
|---|---|
| Principais autores: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
National Academy of Sciences
2000
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC27030/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10984532/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.97.19.10365 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
